← Back to Search

Device

Exoskeleton Walking for Cerebral Palsy

Phase < 1
Recruiting
Research Sponsored by Northern Arizona University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Gross Motor Function Classification Level I, II, or III
Diagnosis of cerebral palsy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of one week
Awards & highlights

Study Summary

"This trial aims to test the use of ankle exoskeletons to help people with cerebral palsy in everyday settings."

Who is the study for?
This trial is for individuals with cerebral palsy who can walk at least 20 minutes with or without help. They must fit into the exoskeleton device and not have knee issues while walking. Participants should be able to say yes to joining, or if non-verbal, show agreement through gestures interpreted by parents.Check my eligibility
What is being tested?
The study is testing a wearable ankle exoskeleton against normal walking to see how it helps in daily life for those with cerebral palsy. It's a practical test of the technology outside of lab conditions.See study design
What are the potential side effects?
While specific side effects are not listed, potential risks may include discomfort from wearing the device, skin irritation where it touches the body, and muscle fatigue due to altered walking patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can walk with or without walking aids or assistance.
Select...
I have been diagnosed with cerebral palsy.
Select...
I can walk for 20 minutes, with or without help.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of one week
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of one week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Walking speed
Secondary outcome measures
Heart-rate
Perceived exertion
Step length

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Exoskeleton WalkingExperimental Treatment1 Intervention
Walking with ankle exoskeleton assistance
Group II: Normal walkingPlacebo Group1 Intervention
Walking under normal conditions (no exoskeleton)

Find a Location

Who is running the clinical trial?

Northern Arizona UniversityLead Sponsor
32 Previous Clinical Trials
6,712 Total Patients Enrolled
5 Trials studying Cerebral Palsy
136 Patients Enrolled for Cerebral Palsy

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the necessary criteria to participate in this research study?

"Individuals aged between 12 and 45 with a diagnosis of cerebral palsy are eligible for participation in this study, which has openings for a total of 10 participants."

Answered by AI

Are there any available positions for patients in this ongoing clinical trial?

"As per the details available on clinicaltrials.gov, this research is presently in need of volunteers. The trial was initially uploaded on October 25th, 2023 and last revised on January 29th, 2024."

Answered by AI

How large is the participant pool for this clinical trial in its entirety?

"Indeed, the details on clinicaltrials.gov highlight that this particular medical trial is actively seeking suitable participants. First appearing online on October 25th, 2023 and subsequently updated on January 29th, 2024, the study aims to enroll a total of ten patients from one designated site."

Answered by AI

Is the study open to participants who are younger than 75 years old?

"Individuals aged between 12 and 45 are eligible for participation in this research. The database reveals a total of 159 trials catering to minors under 18 years old, while there are also 25 studies targeting those above the age of 65."

Answered by AI
~7 spots leftby May 2025